ZFP36L1 Negatively Regulates Erythroid Differentiation of CD34+ Hematopoietic Stem Cells by Interfering with the Stat5b Pathway
出版年份 2010 全文链接
标题
ZFP36L1 Negatively Regulates Erythroid Differentiation of CD34+ Hematopoietic Stem Cells by Interfering with the Stat5b Pathway
作者
关键词
-
出版物
MOLECULAR BIOLOGY OF THE CELL
Volume 21, Issue 19, Pages 3340-3351
出版商
American Society for Cell Biology (ASCB)
发表日期
2010-08-12
DOI
10.1091/mbc.e10-01-0040
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Vitamin D3/Hox-A10 Pathway Supports MafB Function during the Monocyte Differentiation of Human CD34+ Hemopoietic Progenitors
- (2014) C. Gemelli et al. JOURNAL OF IMMUNOLOGY
- Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis
- (2009) D. J. Stumpo et al. BLOOD
- Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms
- (2009) Lizz F. Grimwade et al. BRITISH JOURNAL OF HAEMATOLOGY
- IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor-Initiated Apoptosis via Repression of FLICE-like Protein Expression
- (2009) D. Yang et al. CANCER RESEARCH
- The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis
- (2009) S. E. Brennan et al. CANCER RESEARCH
- The Interferon Consensus Sequence Binding Protein (ICSBP/IRF8) Activates Transcription of theFANCFGene during Myeloid Differentiation
- (2009) Gurveen Saberwal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Acute Lymphoblastic Leukemia-associated JAK2 L611S Mutant Induces Tumorigenesis in Nude Mice
- (2009) Megumi Funakoshi-Tago et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tristetraprolin Is Required for Full Anti-Inflammatory Response of Murine Macrophages to IL-10
- (2009) B. Schaljo et al. JOURNAL OF IMMUNOLOGY
- Control of mRNA decay by phosphorylation of tristetraprolin
- (2008) Heike Sandler et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Myeloproliferative disorders
- (2008) R. L. Levine et al. BLOOD
- Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2
- (2008) F. Grebien et al. BLOOD
- Single-Cell Profiling Identifies Aberrant STAT5 Activation in Myeloid Malignancies with Specific Clinical and Biologic Correlates
- (2008) Nikesh Kotecha et al. CANCER CELL
- Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera
- (2008) Gerlinde Wernig et al. CANCER CELL
- Tristetraprolin Down-regulates Interleukin-8 and Vascular Endothelial Growth Factor in Malignant Glioma Cells
- (2008) E. Suswam et al. CANCER RESEARCH
- The Signal Transducer STAT5 Inhibits Plasmacytoid Dendritic Cell Development by Suppressing Transcription Factor IRF8
- (2008) Eiji Esashi et al. IMMUNITY
- Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments
- (2008) Chen-Feng Qi et al. IMMUNOLOGIC RESEARCH
- IRF8 regulates myeloid and B lymphoid lineage diversification
- (2008) Hongsheng Wang et al. IMMUNOLOGIC RESEARCH
- Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2
- (2008) Joseph M. Gozgit et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Jak2/Stat5 Signaling in Mammogenesis, Breast Cancer Initiation and Progression
- (2008) Kay-Uwe Wagner et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- In vivo identification of novel STAT5 target genes
- (2008) B. Basham et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search